Gene Therapy News and Research

RSS
Scripps Research wins $4 million CIRM grant to develop novel platform for neurodevelopmental disorders

Scripps Research wins $4 million CIRM grant to develop novel platform for neurodevelopmental disorders

Les Turner Symposium on ALS brings researchers and clinicians to discuss new research findings

Les Turner Symposium on ALS brings researchers and clinicians to discuss new research findings

International experts publish guidelines on the administration of gene therapy for hereditary hearing loss

International experts publish guidelines on the administration of gene therapy for hereditary hearing loss

New gene-editing method can correct many disease-causing mutations in mammalian cells

New gene-editing method can correct many disease-causing mutations in mammalian cells

Researchers achieve proof of concept for generating eggs from somatic cells

Researchers achieve proof of concept for generating eggs from somatic cells

New European trial tests subcutaneous EEG technology for people with epilepsy

New European trial tests subcutaneous EEG technology for people with epilepsy

Longevity gene offers hope for children with progeria

Longevity gene offers hope for children with progeria

Experimental gene therapy restores immune system function in children with genetic immune disorder

Experimental gene therapy restores immune system function in children with genetic immune disorder

Gene therapy shows long-term success in children with rare immune disorder

Gene therapy shows long-term success in children with rare immune disorder

New gene therapy reverses symptoms of SYNGAP1-related disorders in mice

New gene therapy reverses symptoms of SYNGAP1-related disorders in mice

The ISSCR releases new resource to accelerate the development of PSC-derived therapies

The ISSCR releases new resource to accelerate the development of PSC-derived therapies

Empowering genomics research with cloud-based innovation

Empowering genomics research with cloud-based innovation

Aptamer expands into targeted radiopharmaceuticals with major top 3 pharma contract

Aptamer expands into targeted radiopharmaceuticals with major top 3 pharma contract

New partnership brings next-generation cell isolation solutions to researchers advancing cell and gene therapy development

New partnership brings next-generation cell isolation solutions to researchers advancing cell and gene therapy development

Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus

Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus

Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases

Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

Gut microbial imbalance linked to chronic sickle cell disease pain

Gut microbial imbalance linked to chronic sickle cell disease pain

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

FUJIFILM Biosciences introduces BalanCD HEK293 perfusion a medium to enable gene therapy production

FUJIFILM Biosciences introduces BalanCD HEK293 perfusion a medium to enable gene therapy production

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.